Literature DB >> 28903158

Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.

Steven J Katz1,2, Sarah T Hawley1,2,3, Ann S Hamilton4, Kevin C Ward5, Monica Morrow6, Reshma Jagsi7, Timothy P Hofer8.   

Abstract

Importance: Rates of contralateral prophylactic mastectomy (CPM) have markedly increased but we know little about the influence of surgeons on variability of the procedure in the community. Objective: To quantify the influence of the attending surgeon on rates of CPM and clinician attitudes that explained it. Design, Setting, and Participants: In this population-based survey study, we identified 7810 women with stages 0 to II breast cancer treated in 2013 to 2015 through the Surveillance, Epidemiology, and End Results registries of Georgia and Los Angeles County. Surveys were sent approximately 2 months after surgery. Surveys were also sent to 488 attending surgeons identified by the patients. Main Outcomes and Measures: We conducted multilevel analyses to examine the impact of surgeon influence on variations in patient receipt of CPM using information from patient and surgeon surveys merged to Surveillance, Epidemiology, and End Results data.
Results: A total of 5080 women responded to the survey (70% response rate), and 377 surgeons responded (77% response rate). The mean (SD) age of responding women was 61.9 (11) years; 28% had an increased risk of second primary cancer, and 16% received CPM. Half of surgeons (52%) practiced for more than 20 years and 30% treated more than 50 new patients with breast cancer annually. Attending surgeon explained a large amount (20%) of the variation in CPM, controlling for patient factors. The odds of a patient receiving CPM increased almost 3-fold (odds ratio, 2.8; 95% CI, 2.1-3.4) if she saw a surgeon with a practice approach 1 SD above a surgeon with the mean CPM rate (independent of age, diagnosis date, BRCA status, and risk of second primary). One-quarter (25%) of the surgeon influence was explained by attending attitudes about initial recommendations for surgery and responses to patient requests for CPM. The estimated rate of CPM was 34% for surgeons who least favored initial breast conservation and were least reluctant to perform CPM vs 4% for surgeons who most favored initial breast conservation and were most reluctant to perform CPM. Conclusions and Relevance: In this study, attending surgeons exerted influence on the likelihood of receipt of CPM after a breast cancer diagnosis. Variations in surgeon attitudes about recommendations for surgery and response to patient requests for CPM explain a substantial amount of this influence.

Entities:  

Mesh:

Year:  2018        PMID: 28903158      PMCID: PMC5833615          DOI: 10.1001/jamasurg.2017.3415

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   16.681


  15 in total

Review 1.  Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.

Authors:  Kelly K Hunt; David M Euhus; Judy C Boughey; Anees B Chagpar; Sheldon M Feldman; Nora M Hansen; Swati A Kulkarni; David R McCready; Eleftherios P Mamounas; Lee G Wilke; Kimberly J Van Zee; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2016-12-08       Impact factor: 5.344

2.  Are mastectomy rates really increasing in the United States?

Authors:  Elizabeth B Habermann; Andrea Abbott; Helen M Parsons; Beth A Virnig; Waddah B Al-Refaie; Todd M Tuttle
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

3.  Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Authors:  Mary B Daly; Robert Pilarski; Jennifer E Axilbund; Michael Berry; Saundra S Buys; Beth Crawford; Meagan Farmer; Susan Friedman; Judy E Garber; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K Litton; Lisa Madlensky; P Kelly Marcom; Sofia D Merajver; Kenneth Offit; Tuya Pal; Huma Rana; Gwen Reiser; Mark E Robson; Kristen Mahoney Shannon; Elizabeth Swisher; Nicoleta C Voian; Jeffrey N Weitzel; Alison Whelan; Myra J Wick; Georgia L Wiesner; Mary Dwyer; Rashmi Kumar; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2016-02       Impact factor: 11.908

4.  Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.

Authors:  Tari A King; Rita Sakr; Sujata Patil; Inga Gurevich; Michelle Stempel; Michelle Sampson; Monica Morrow
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

5.  Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.

Authors:  Reshma Jagsi; Jing Jiang; Adeyiza O Momoh; Amy Alderman; Sharon H Giordano; Thomas A Buchholz; Steven J Kronowitz; Benjamin D Smith
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

6.  Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.

Authors:  Todd M Tuttle; Elizabeth B Habermann; Erin H Grund; Todd J Morris; Beth A Virnig
Journal:  J Clin Oncol       Date:  2007-10-22       Impact factor: 44.544

7.  Surgeon recommendations and receipt of mastectomy for treatment of breast cancer.

Authors:  Monica Morrow; Reshma Jagsi; Amy K Alderman; Jennifer J Griggs; Sarah T Hawley; Ann S Hamilton; John J Graff; Steven J Katz
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

8.  Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.

Authors:  Natalie B Jones; John Wilson; Linda Kotur; Julie Stephens; William B Farrar; Doreen M Agnese
Journal:  Ann Surg Oncol       Date:  2009-06-09       Impact factor: 5.344

9.  Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .

Authors:  Allison W Kurian; Kent A Griffith; Ann S Hamilton; Kevin C Ward; Monica Morrow; Steven J Katz; Reshma Jagsi
Journal:  JAMA       Date:  2017-02-07       Impact factor: 157.335

10.  Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.

Authors:  Steven J Katz; Nancy K Janz; Paul Abrahamse; Lauren P Wallner; Sarah T Hawley; Lawrence C An; Kevin C Ward; Ann S Hamilton; Monica Morrow; Reshma Jagsi
Journal:  JAMA Surg       Date:  2017-07-01       Impact factor: 16.681

View more
  12 in total

1.  Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.

Authors:  Thomas A D'Agostino; Abenaa M Brewster; Susan K Peterson; Isabelle Bedrosian; Patricia A Parker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

Review 2.  Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Authors:  Giacomo Montagna; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-28       Impact factor: 4.512

3.  Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population.

Authors:  Rachel C Hooper; Jessica Hsu; Anthony Duncan; Jessica M Bensenhaver; Lisa A Newman; Kelly M Kidwell; Kevin C Chung; Adeyiza O Momoh
Journal:  Plast Reconstr Surg       Date:  2019-05       Impact factor: 4.730

4.  Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.

Authors:  Steven J Katz; Irina Bondarenko; Kevin C Ward; Ann S Hamilton; Monica Morrow; Allison W Kurian; Timothy P Hofer
Journal:  JAMA Surg       Date:  2018-10-01       Impact factor: 14.766

Review 5.  Contralateral prophylactic mastectomy and implications for breast reconstruction.

Authors:  Katherine B Santosa; Jeremie D Oliver; Adeyiza O Momoh
Journal:  Gland Surg       Date:  2021-01

6.  Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer.

Authors:  Archana Radhakrishnan; Lauren P Wallner; Ted A Skolarus; Arvin K George; Bradley H Rosenberg; Paul Abrahamse; Sarah T Hawley
Journal:  J Urol       Date:  2022-05-06       Impact factor: 7.600

7.  Impact of age, rurality and distance in predicting contralateral prophylactic mastectomy for breast cancer in a Midwestern state: a population-based study.

Authors:  Ingrid M Lizarraga; Amanda R Kahl; Ellie Jacoby; Mary E Charlton; Charles F Lynch; Sonia L Sugg
Journal:  Breast Cancer Res Treat       Date:  2021-02-13       Impact factor: 4.624

8.  Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.

Authors:  Ingrid M Lizarraga; Mary C Schroeder; Ismail Jatoi; Sonia L Sugg; Amy Trentham-Dietz; Laurel Hoeth; Elizabeth A Chrischilles
Journal:  Ann Surg Oncol       Date:  2021-07-12       Impact factor: 5.344

9.  Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty.

Authors:  Ken Resnicow; Minal R Patel; M Chandler Mcleod; Steven J Katz; Reshma Jagsi
Journal:  Breast Cancer Res Treat       Date:  2018-09-26       Impact factor: 4.624

10.  Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States.

Authors:  Katharine Yao; Richard Bleicher; Meena Moran; Cecilia Chang; Jill Dietz; Vered Stearns; James Connolly; Terry Sarantou; Scott Kurtzman
Journal:  Cancer Med       Date:  2020-03-11       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.